Life sciences news
-
S-Biomedic announces completion of prestigious financing with European Innovation Council Fund
Friday October 1st 2021
Read more
-
Biotalys strengthens executive team with the appointment of Patrick McDonnell as Chief Business Officer
Thursday September 30th 2021
Read more
-
OXURION announces positive results from Part A of Phase 2 Study evaluating THR-149 for treatment of Diabetic Macular Edema (DME)
Thursday September 30th 2021
Read more
-
Bone Therapeutics signs research partnership with Implant Therapeutics to access induced Pluripotent Stem Cells (iPSC)
Wednesday September 29th 2021
Read more
-
Mithra announces topline results for COVID-19 Phase II Study
Friday September 24th 2021
Read more
-
Biocartis announces restart of its high-throughput cartridge manufacturing line
Thursday September 23rd 2021
Read more
-
Rewind Therapeutics appoints Anja Harmeier, PhD, MBA, as Chief Executive Officer
Wednesday September 22nd 2021
Read more
-
Donesta® Phase III: recruitment completion of American study and additional recruitment in the European study
Wednesday September 22nd 2021
Read more
-
Become a flanders.bio member
Your news here?
-
Mithra announces an update on PeriNesta®
Wednesday September 22nd 2021
Read more
-
Bone Therapeutics appoints Lieve Creten as interim Chief Financial Officer
Tuesday September 21st 2021
Read more
-
Galapagos announces positive CHMP opinion for Jyseleca® (filgotinib) for the treatment of adults with moderately to severely active ulcerative colitis
Friday September 17th 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
